Evotec SE (OTCMKTS:EVTCY – Get Rating)'s share price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $9.81 and last traded at $9.85, with a volume of 6946 shares. The stock had previously closed at $10.16.
Evotec Stock Performance
The firm has a 50 day moving average of $8.74 and a 200-day moving average of $10.04. The stock has a market capitalization of $3.25 billion, a PE ratio of 57.20 and a beta of 0.98. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
Evotec Company Profile
(Get Rating)
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
See Also
- Get a free copy of the StockNews.com research report on Evotec (EVTCY)
- Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
- SoFi Technologies Smashes Earnings but Beware the Fed Decision
- Buying The Dip In Colgate-Palmolive
- Mullen Automotive On Hiring Spree, What Could That Mean?
- InterDigital Raises Its Earnings Guidance
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.